Tocilizumab's efficacy in COVID-19 patients is determined by the presence of cytokine storm. Andrianopoulos I, Papathanasiou A, Papathanakos G, Chaidos A, et al. J Med Virol 2020 Jun 22. doi: 10.1002/jmv.26209.

Read + Share

Amedeo Smart

Independent Medical Education

Andrianopoulos I, Papathanasiou A, Papathanakos G, Chaidos A, et al. Tocilizumab's efficacy in COVID-19 patients is determined by the presence of cytokine storm. J Med Virol 2020 Jun 22. doi: 10.1002/jmv.26209.
PMID: 32568411